Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypertriglyceridemia: HELP
Craig B. Granowitz
Based on 10 articles published since 2010
(Why 10 articles?)
||||
Expertise Level
The expertise of Craig B. Granowitz ranks in the
  • Top 0.53%
  • ... of 13,274 published authors worldwide on Hypertriglyceridemia
  • ... from 2010 through 2020
  • ... based on contributions to 10 articles on the topic.
Graphical view (beta)
Aliases Granowitz, Craig   ·   Granowitz, Craig B
Work Locations
Details
Most likely:    Miscellaneous cities in New Jersey      
2019
  • From Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.) · FACT (French Alliance for Cardiovascular Trials), Département Hospitalo-Universitaire FIRE (Fibrose, Inflammation, and Remodeling), Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Université Paris-Diderot, INSERM Unité 1148, Paris (P.G.S.) · National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.) · the Department of Medicine, University of Maryland School of Medicine, Baltimore (M.M.) · the Utah Lipid Center, Salt Lake City (E.A.B.) · the Office of Health Promotion and Disease Prevention, Department of Medicine, Emory University School of Medicine, Atlanta (T.A.J.) · Amarin Pharma, Bedminster, NJ (S.B.K., R.T.D.J., R.A.J., L.J., C.G.) · Montreal Heart Institute, Université de Montréal, Montreal (J.-C.T.) · and the Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.). · Pubmed 30415628
  • CGH Medical Center, Sterling, IL, USA. · Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Amarin Pharma Inc, Bedminster, NJ, USA. · Optum, Eden Prairie, MN, USA. · Pubmed 31824165
  • MedStar Heart & Vascular Institute, MedStar Washington Hospital Center, Washington, DC. · Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT. · Medical Affairs, Amarin Pharma, Inc, Bedminster, NJ. · Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT. · Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD. · Department of Medicine, School of Medicine University of California, Irvine, CA. · Health Economics and Outcomes Research, Optum Research Database, Eden Prairie, MN. · MedStar Heart & Vascular Institute, MedStar Washington Hospital Center, Washington, DC. Electronic address: · Pubmed 31427271
  • Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Preventive Cardiology, CGH Medical Center, Sterling, IL. Electronic address: · Department of Medical Affairs, Amarin Pharma, Inc, Bedminster, NJ. · Department of Health Economics and Outcomes Research, Optum, Inc, Eden Prairie, MN. · Pubmed 31405751
  • Department of Medicine, Baylor College of Medicine and the Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Amarin Pharma Inc, Bedminster, NJ, USA. · Clinical Research, Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA. · Medical Affairs, Amarin Pharma Inc, Bedminster, NJ, USA. · Research and Development, Amarin Pharma Inc, Bedminster, NJ, USA. · Pubmed 30788718
  • Kaiser Permanente Center for Health Research, Portland, Oregon. · Amarin Pharma Inc., Bedminster, New Jersey. · Kaiser Permanente Southern California, Pasadena, California. · Oregon Health and Science University, Portland, Oregon. · Pubmed 30225881
2018
  • Kaiser Permanente Center for Health Research, Portland, Oregon. Electronic address: · Amarin Pharma Inc., Bedminster, New Jersey. · Kaiser Permanente Southern California, Pasadena, California. · Kaiser Permanente Center for Health Research, Portland, Oregon. · Oregon Health & Science University, Portland, Oregon. · Pubmed 30086877
  • Kaiser Permanente Center for Health Research, Portland, Oregon. · Amarin Pharma Inc., Bedminster, New Jersey. · Kaiser Permanente Southern California, Pasadena, California. · Oregon Health & Science University, Portland, Oregon. · Pubmed 29850861
Probable:    Miscellaneous cities in USA      
2019
  • a Institute of Congestive Heart Failure, Abrazo Arizona Heart Hospital , Phoenix , AZ , USA. · b Nephrology Division and Nephrology Fellowship Program, Baylor University Medical Center , Dallas , TX , USA. · c Department of Medicine, Baylor College of Medicine and the Houston Methodist DeBakey Heart and Vascular Center , Houston , TX , USA. · d Louisville Metabolic and Atherosclerosis Research Center , Louisville , KY , USA. · e Medical Affairs, Amarin Pharma Inc ., Bedminster , NJ , USA. · f Clinical Development, Amarin Pharma Inc ., Bedminster , NJ , USA. · Pubmed 31306043
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Craig B. Granowitz in 2010-2020 about Hypertriglyceridemia:

  • Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. 2019
  • Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200-499 mg/dL) Are Significant Predictors of New Heart Failure Diagnosis: A Real-World Analysis of High-Risk Statin-Treated Patients. 2019
  • The economic burden of hypertriglyceridemia among US adults with diabetes or atherosclerotic cardiovascular disease on statin therapy. 2019
  • Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients. 2019
  • Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides. 2019
  • Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study. 2019
  • Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol. 2019
  • High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real-World Administrative Claims Analysis of Statin-Treated Patients With High Residual Cardiovascular Risk. 2018
  • Comparison of Medical Care Utilization and Costs Among Patients With Statin-Controlled Low-Density Lipoprotein Cholesterol With Versus Without Hypertriglyceridemia. 2018
  • Increased Cardiovascular Risk in Hypertriglyceridemic Patients With Statin-Controlled LDL Cholesterol. 2018
Show List of Full Article Records
Google Searches

Learn more about Craig B. Granowitz using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous cities in New Jersey
Miscellaneous cities in USA
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous cities in New Jersey
2019
  • From Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.) · FACT (French Alliance for Cardiovascular Trials), Département Hospitalo-Universitaire FIRE (Fibrose, Inflammation, and Remodeling), Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Université Paris-Diderot, INSERM Unité 1148, Paris (P.G.S.) · National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.) · the Department of Medicine, University of Maryland School of Medicine, Baltimore (M.M.) · the Utah Lipid Center, Salt Lake City (E.A.B.) · the Office of Health Promotion and Disease Prevention, Department of Medicine, Emory University School of Medicine, Atlanta (T.A.J.) · Amarin Pharma, Bedminster, NJ (S.B.K., R.T.D.J., R.A.J., L.J., C.G.) · Montreal Heart Institute, Université de Montréal, Montreal (J.-C.T.) · and the Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.). · Pubmed 30415628
  • CGH Medical Center, Sterling, IL, USA. · Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Amarin Pharma Inc, Bedminster, NJ, USA. · Optum, Eden Prairie, MN, USA. · Pubmed 31824165
  • MedStar Heart & Vascular Institute, MedStar Washington Hospital Center, Washington, DC. · Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT. · Medical Affairs, Amarin Pharma, Inc, Bedminster, NJ. · Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT. · Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD. · Department of Medicine, School of Medicine University of California, Irvine, CA. · Health Economics and Outcomes Research, Optum Research Database, Eden Prairie, MN. · MedStar Heart & Vascular Institute, MedStar Washington Hospital Center, Washington, DC. Electronic address: · Pubmed 31427271
  • Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Preventive Cardiology, CGH Medical Center, Sterling, IL. Electronic address: · Department of Medical Affairs, Amarin Pharma, Inc, Bedminster, NJ. · Department of Health Economics and Outcomes Research, Optum, Inc, Eden Prairie, MN. · Pubmed 31405751
  • Department of Medicine, Baylor College of Medicine and the Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Amarin Pharma Inc, Bedminster, NJ, USA. · Clinical Research, Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA. · Medical Affairs, Amarin Pharma Inc, Bedminster, NJ, USA. · Research and Development, Amarin Pharma Inc, Bedminster, NJ, USA. · Pubmed 30788718
  • Kaiser Permanente Center for Health Research, Portland, Oregon. · Amarin Pharma Inc., Bedminster, New Jersey. · Kaiser Permanente Southern California, Pasadena, California. · Oregon Health and Science University, Portland, Oregon. · Pubmed 30225881
2018
  • Kaiser Permanente Center for Health Research, Portland, Oregon. Electronic address: · Amarin Pharma Inc., Bedminster, New Jersey. · Kaiser Permanente Southern California, Pasadena, California. · Kaiser Permanente Center for Health Research, Portland, Oregon. · Oregon Health & Science University, Portland, Oregon. · Pubmed 30086877
  • Kaiser Permanente Center for Health Research, Portland, Oregon. · Amarin Pharma Inc., Bedminster, New Jersey. · Kaiser Permanente Southern California, Pasadena, California. · Oregon Health & Science University, Portland, Oregon. · Pubmed 29850861
Miscellaneous cities in USA
2019
  • a Institute of Congestive Heart Failure, Abrazo Arizona Heart Hospital , Phoenix , AZ , USA. · b Nephrology Division and Nephrology Fellowship Program, Baylor University Medical Center , Dallas , TX , USA. · c Department of Medicine, Baylor College of Medicine and the Houston Methodist DeBakey Heart and Vascular Center , Houston , TX , USA. · d Louisville Metabolic and Atherosclerosis Research Center , Louisville , KY , USA. · e Medical Affairs, Amarin Pharma Inc ., Bedminster , NJ , USA. · f Clinical Development, Amarin Pharma Inc ., Bedminster , NJ , USA. · Pubmed 31306043
Unspecified
2018
  • 1 CGH Medical Center Sterling IL. · 2 Johns Hopkins University School of Medicine Baltimore MD. · 3 Amarin Pharma Inc Bedminster NJ. · 4 Optum Eden Prairie MN. · Pubmed 30371242
Yearly article counts 07300000000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.